As of Dec 02
| +3.47 / +3.46%|
The 1 analysts offering 12-month price forecasts for Taro Pharmaceutical Industries Ltd have a median target of 135.00, with a high estimate of 135.00 and a low estimate of 135.00. The median estimate represents a +30.08% increase from the last price of 103.78.
The current consensus among 2 polled investment analysts is to Buy stock in Taro Pharmaceutical Industries Ltd. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.